Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-008274
Filing Date
2025-03-17
Accepted
2025-03-17 21:04:15
Documents
1
Period of Report
2025-03-13

Document Format Files

Seq Description Document Type Size
1 form4-03182025_010312.html 4  
1 form4-03182025_010312.xml 4 3753
  Complete submission text file 0001415889-25-008274.txt   5188
Mailing Address 565 EVERETT AVENUE PALO ALTO CA 94301
Business Address
AKKARAJU SRINIVAS (Reporting) CIK: 0001253170 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41614 | Film No.: 25746259

Mailing Address 150 N. RADNOR CHESTER ROAD SUITE F200 RADNOR PA 19087
Business Address 150 N. RADNOR CHESTER ROAD SUITE F200 RADNOR PA 19087 (888) 378-6240
Mineralys Therapeutics, Inc. (Issuer) CIK: 0001933414 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)